COMMUNIQUÉS West-GlobeNewswire
-
Un chirurgien saoudien récompensé pour avoir réalisé la première transplantation cardiaque robotisée au monde
24/10/2024 - 19:21 -
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
24/10/2024 - 20:10 -
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
24/10/2024 - 21:03 -
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
24/10/2024 - 22:00 -
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
24/10/2024 - 22:01 -
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
24/10/2024 - 22:05 -
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
24/10/2024 - 22:05 -
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
24/10/2024 - 22:05 -
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
24/10/2024 - 22:05 -
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
24/10/2024 - 22:05 -
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
24/10/2024 - 22:05 -
The Ensign Group Reports Third Quarter 2024 Results; Raises Annual Earnings and Revenue Guidance
24/10/2024 - 22:07 -
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
24/10/2024 - 22:10 -
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
24/10/2024 - 22:30 -
Vision Sensing Acquisition Corp. Announces Securities Suspension Date and Redemption Amount
24/10/2024 - 22:30 -
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024
23/10/2024 - 14:30 -
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
23/10/2024 - 14:30 -
Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
23/10/2024 - 14:30 -
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
23/10/2024 - 14:31
Pages